IBRX Congressional Stock Trades
ImmunityBio, Inc.
Last disclosed trade Sep 30
Every disclosed trade in IBRX by members of Congress under the STOCK Act, parsed by Coldpine. Informational only, sourced from public filings. Not investment advice.
Sample · the intelligence layer
Lisa McClain · Bought $IBRX · Sep 28 · $1K–$15K
Every disclosed trade in the database gets this treatment: a four-factor score and a written read from Coldpine’s AI-based analysis. Informational only, not investment advice. Create a free account for every scored trade →
Follow $IBRX
Get notified when any member of Congress trades $IBRX. Free, no card, no spam.
The record on $IBRX
Coldpine has parsed 2 disclosed trades in $IBRX by 1 member of Congress, drawn from 1 periodic transaction report dated Sep 28, 2026 through Sep 30, 2026. All of them came from House members, all filed by Republicans.
Of the 2 trades with a known filing lag, every one was reported inside the STOCK Act's 45-day window. The median lag was 13 days. The longest was 14 days: a $IBRX purchase by Lisa McClain dated Sep 28, 2026, disclosed Oct 12, 2026. How late filing is measured across all of Congress is in the late-filers study.
2 of the 2 trades that list an account holder (100%) were reported under a spouse, dependent child, or joint account rather than the member directly.
Members who trade IBRX
Recent disclosed trades in IBRX
| Date | Member | Type | Amount |
|---|---|---|---|
| Sep 30 | Lisa McClain(MI) | buy | $1K–$15K |
| Sep 28 | Lisa McClain(MI) | buy | $1K–$15K |
From Coldpine Research
Data sourced from public STOCK Act disclosures. Coldpine is a publisher of intelligence on congressional disclosures, not an investment adviser. See full history and scores, free with an account →